A recent study reported that stromal overexpression of the SNAIL transcription factor SNAI2 is linked to poor prognosis in patients with Luminal B HER2+ breast cancer, while the absence of SNAI2 in the stroma of Luminal B HER2+ breast tumor cells is associated with lower levels of plasma Ang232. The gene discussed is ERBB2; the disease is breast carcinoma.